Upgrade to SI Premium - Free Trial

Biogen (BIIB) PT Raised to $380 at Oppenheimer

January 29, 2019 5:29 PM
Oppenheimer analyst Jay Olson raised the price target on ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles